Melatonin and carcinogenesis in mice: the 50th anniversary of relationships

Vladimir N. Anisimov; Alexey G. Golubev

doi:10.18632/oncotarget.28537

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Perspectives:

Melatonin and carcinogenesis in mice: the 50th anniversary of relationships

Vladimir N. Anisimov _ and Alexey G. Golubev

PDF | Full Text | How to cite | Press Release

Oncotarget. 2023; 14:972-976. https://doi.org/10.18632/oncotarget.28537

Metrics: PDF 420 views | Full Text 2676 views | ?

Abstract

Vladimir N. Anisimov1^,* and Alexey G. Golubev1^,*

1 Department of Carcinogenesis and Oncogerontology, N.N. Petrov National Medical Research Center of Oncology, Saint Petersburg 197758, Russia

* The authors contributed equally to this work

Correspondence to:

Vladimir N. Anisimov,

email:

[email protected]

Keywords: cancer; melatonin; mice

Received: November 07, 2023 Accepted: November 16, 2023 Published: December 12, 2023

Copyright: © 2023 Anisimov and Golubev. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

The history of studies of melatonin effects on cancer in mice is outlined, the main lesson being that the systemic in vivo effects of melatonin on animals may overwhelm the in vitro effects found using tissue explants or cell cultures. In particular, the timing of melatonin administration is of crucial importance for using the drug, which is freely available over counter and thus needs no licensing for its applications in oncology.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28537

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Perspectives:

Melatonin and carcinogenesis in mice: the 50th anniversary of relationships

Abstract